![Great News For Bladder Cancer Patients](http://townsquare.media/site/126/files/2015/01/bladder-cancer.jpg?w=980&q=75)
Great News For Bladder Cancer Patients
Pharmaceutical company Abbott just announced this week that they have signed an exclusive licensing agreement with the Institut Curie for a biomarker for bladder cancer!. Genetic mutations in FGFR3 can be used for early detection, disease monitoring, & predicting patient outcomes in both urine & tissue-based testing. FGFR3 ...